DU4475 Cells
General information
Description | The DU4475 cell line is a human breast cancer cell line derived from a metastatic site. It is characterized by its aggressive nature and poor differentiation, often used in research to study the mechanisms of cancer metastasis and progression. The cell line has been utilized extensively to explore the therapeutic targets and the efficacy of anti-cancer drugs in treating highly invasive breast cancer types. Genetically, DU4475 exhibits a high level of genetic instability, which is a hallmark of many cancer cells. This feature makes it a valuable model for studying the genetic and molecular events leading to cancer development and progression. Research involving DU4475 often focuses on the pathways that regulate cancer cell growth, survival, and resistance to chemotherapy, making it a critical resource for oncological studies aiming to develop more effective cancer treatments. |
---|---|
Organism | Human |
Tissue | Breast |
Disease | Breast carcinoma |
Metastatic site | Skin |
Applications | 3D cell culture, Immuno-oncology |
Synonyms | Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475 |
Characteristics
Age | 62 years |
---|---|
Gender | Female |
Ethnicity | European |
Morphology | Epithelial |
Growth properties | Clusters in Suspension |
Identifiers / Biosafety / Citation
Citation | DU4475 (Cytion catalog number 300371) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Isoenzymes | AK-1, 1, ES-D, 1, G6PD, B, GLO-I, 2, Me-2, 2, PGM1, 1-2, PGM3, 1 |
---|---|
Tumorigenic | Yes, in nude mice |
Viruses | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
Karyotype | human flat-moded near-tetraploid karyotype with 12% polyploidy - 88-93xxxx, +1, +1, -5, -6, +9, -10, -10, +15, +15, -16, -16, +22, +4mar, i(1q)x2, ?add(1)(p35-36)x2, ?i(5p)x2, add(6)(p11), add(6)(p1?), del(6)(q25), add(9)(q35), del(11)(q24)x2, add(15)(p11)x2, add(17)(p1?)x2, del(21)(q22.2)x2 - sideline with -20, -20, +del(7)(p11) - gain of 1q and loss of 6q typical in breast carcinoma - resembles published karyotype |
Handling
Culture Medium | RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 15% heat-inactivated FBS |
Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 2 x 10^5 cells/ml and keep the cell concentration within the range of 1 x 10^5 to 1 x 10^6 cells/ml for optimal growth. |
Freeze medium | CM-1 (Cytion catalog number 800100) |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
STR profile |
Amelogenin: x,x
CSF1PO: 9,12
D13S317: 11,14
D16S539: 11,12
D5S818: 11
D7S820: 9,1
TH01: 6,8
TPOX: 8
vWA: 17
D3S1358: 14,16
D21S11: 29,31.2
D18S51: 14,16
Penta E: 7,13
Penta D: 13,14
D8S1179: 10,13
FGA: 22,25
D6S1043: 11
D2S1338: 20,25
D12S391: 18.3,25
D19S433: 14
|